Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1,4-dihydro-7-(3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic Acid
2. Ag 7352
3. Ag-7352
4. Ag7352
5. Sns-595
6. Vosaroxin
1. Vosaroxin
2. 175414-77-4
3. Sns-595
4. Ag-7352
5. Ag 7352
6. Spc-595
7. Vosaroxin (usan)
8. Vosaroxin [usan]
9. K6a90iiz19
10. 7-((3s,4s)-3-methoxy-4-(methylamino)pyrrolidin-1-yl)-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid
11. Quinprezo
12. 174726-60-4
13. 7-((3s,4s)-3-methoxy-4-(methylamino)pyrrolidin-1-yl)-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid.
14. Trans-7-(3-methoxy-4-(methylamino)pyrrolidin-1-yl)-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid
15. Sns 595
16. Spc 595
17. Vosaroxin [usan:inn]
18. Unii-k6a90iiz19
19. 7-[(3s,4s)-3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic Acid
20. Ag7352
21. 1,4-dihydro-7-(3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic Acid
22. Vosaroxin [inn]
23. (+)-ag-7352
24. Vosaroxin [mart.]
25. Vosaroxin [who-dd]
26. Chembl68117
27. Schembl674441
28. Dtxsid50938662
29. Ex-a847
30. Voreloxin;sns-595;ag 7352
31. Mfcd13185156
32. Nsc760764
33. Zinc26186622
34. Akos030526660
35. Cs-0790
36. Db11999
37. Nsc-760764
38. Ac-36005
39. Hy-10534
40. Vosaroxin Hydrochloride, >=98% (hplc)
41. Sw219924-1
42. D08024
43. A911613
44. J-690243
45. Q18395775
46. (+)-7-((3s,4s)-3-methoxy-4-(methylamino)pyrrolidin-1-yl)-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid
47. (+)-7-[3(s)-methoxy-4(s)-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(2-thiazolyl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid
48. 1,8-naphthyridine-3-carboxylic Acid, 1,4-dihydro-7-((3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-
49. 1,8-naphthyridine-3-carboxylic Acid, 1,4-dihydro-7-(3-methoxy-4-(methylamino)-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-, (3s-trans)-
50. 7-[(3s,4s)-3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid
51. 960398-99-6
| Molecular Weight | 401.4 g/mol |
|---|---|
| Molecular Formula | C18H19N5O4S |
| XLogP3 | -0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 5 |
| Exact Mass | 401.11577528 g/mol |
| Monoisotopic Mass | 401.11577528 g/mol |
| Topological Polar Surface Area | 136 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 662 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of acute myeloid leukaemia
L - Antineoplastic and immunomodulating agents
L01 - Antineoplastic agents
L01X - Other antineoplastic agents
L01XX - Other antineoplastic agents
L01XX53 - Vosaroxin
ABOUT THIS PAGE
51
PharmaCompass offers a list of Vosaroxin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vosaroxin manufacturer or Vosaroxin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vosaroxin manufacturer or Vosaroxin supplier.
PharmaCompass also assists you with knowing the Vosaroxin API Price utilized in the formulation of products. Vosaroxin API Price is not always fixed or binding as the Vosaroxin Price is obtained through a variety of data sources. The Vosaroxin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vosaroxin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vosaroxin, including repackagers and relabelers. The FDA regulates Vosaroxin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vosaroxin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vosaroxin supplier is an individual or a company that provides Vosaroxin active pharmaceutical ingredient (API) or Vosaroxin finished formulations upon request. The Vosaroxin suppliers may include Vosaroxin API manufacturers, exporters, distributors and traders.
Vosaroxin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vosaroxin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vosaroxin GMP manufacturer or Vosaroxin GMP API supplier for your needs.
A Vosaroxin CoA (Certificate of Analysis) is a formal document that attests to Vosaroxin's compliance with Vosaroxin specifications and serves as a tool for batch-level quality control.
Vosaroxin CoA mostly includes findings from lab analyses of a specific batch. For each Vosaroxin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vosaroxin may be tested according to a variety of international standards, such as European Pharmacopoeia (Vosaroxin EP), Vosaroxin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vosaroxin USP).
